Tetraphase to Host Conference Call on August 5th to Discuss Second Quarter 2015 Financial Results
July 29, 2015 16:05 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., July 29, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
Tetraphase Pharmaceuticals Announces Appointment of Jacques Dumas, Ph.D. as Chief Scientific Officer
July 15, 2015 09:19 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., July 15, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
Tetraphase Pharmaceuticals to Present at Cantor Fitzgerald's Inaugural Healthcare Conference
July 01, 2015 07:00 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., July 1, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
Tetraphase Pharmaceuticals to Present at Upcoming Conferences
June 16, 2015 08:30 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., June 16, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
Tetraphase Pharmaceuticals Reports First-Quarter 2015 Financial Results
May 06, 2015 16:01 ET
|
Tetraphase Pharmaceuticals, Inc.
Patient Enrollment Completed in IGNITE2, Phase 3 Clinical Trial of Eravacyline for cUTI
Company to Host Conference Call at 4:30 p.m. ET Today
WATERTOWN, Mass., May 6, 2015 (GLOBE NEWSWIRE) --...
Tetraphase to Host Conference Call on May 6th to Discuss First Quarter 2015 Financial Results and Recent Highlights
May 01, 2015 07:00 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., May 1, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
Tetraphase Pharmaceuticals Presents Detailed Results From Phase 3 Trials of Eravacycline at 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
April 27, 2015 07:00 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., April 27, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
Tetraphase Pharmaceuticals Appoints Gerri Henwood to Board of Directors
April 15, 2015 17:15 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., April 15, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
Tetraphase Pharmaceuticals to Present Antibiotics Pipeline Data at 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
April 15, 2015 10:57 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., April 15, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH) today announced eight data presentations at the 25th European Congress of Clinical Microbiology and...
Tetraphase Pharmaceuticals to Present at the 14th Annual Needham Healthcare Conference
April 07, 2015 07:00 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., April 7, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (Nasdaq:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...